CBD OIL

By breeding, we’re really trying to breed for farmable seed that are semi-homogenous, if not homogenous. They give us repeatable aromatic bouquets, but also repeatable agronomic traits that make it easier to farm and easier to harvest. When I say easier to harvest, the uniformity of the crop allows for uniform maturation, which means that you can uniformly harvest. When you have a lot of the variation, so too is there variation in the maturity. So that becomes a big issue.

The biggest thing that it allows us is to drive diversity and assortment. If you think about it, most cannabis producers, especially on a smaller scale, ourselves included at many parts of our iterative cycles, rely on clones.

Clones are really when somebody is taking a bag of seeds and planting them, it’s their favorite plant or the plant that performed or smelled or looked the best to them. So, they select that plant and they make cuttings from it. As a consequence, they end up with a very uniform plant that is needing to be managed in order to keep it in and continue to move forward its progeny. But when you planted those seeds, there were less desirable or different strains that were not selected against for whichever reason. What we find a lot of times nowadays with better genetics is that sometimes breeders will have more than one favorite out of a bag of seeds.

ES: The possibilities seem immense.

KA: A great example is that we were known early on for our Slymer strain, which is an F1 phenotype from Chernobyl, which is from Subcool seeds. They would acknowledge that they have what they would call the Golden Ticket, which was this Slymer phenotype, which for Chernobyl is generally a lemon/chem type of flavor. The Slymer was a very clear lime flavor. So, both of these things were coming out of the same seed line, and it just really depended which expression you got. Similarly, when we’re breeding, back-breeding or crossing different strains, sometimes we’ll get more than one variation that we find desirable. Sometimes we’ll even get recessive traits that will just kind of pop out that are unique and new and interesting from that seed line.

What we do is we make those selections and then we start breeding against those multiple different lines. And that ability to follow what we think is agronomically interesting, as well as what smells interesting and looks like it’ll be an impactful plant, is the consequence of variety. From everything we plant, we end up with anywhere from maybe one to five varieties, depending on where it is in regards to breeding. As we stabilize those individual things, they become an individual particular strain, but maybe earlier on generationally, there was a point where they branched off into three different strains.

ES: How fragile are these genetic lines? If you’re not dialed in as a breeder, is it possible to lose some of the traits that you’re actually trying to select for?

KA: Like all genetic traits, you have dominant and recessive traits. And I won’t suggest to say we know enough about plant yet to say definitively, but it seems like some plants act as better platforms. A lot of times, those are agronomic traits—the structure of the plant, the shape of the plant, the shape of the bud. When we find those good platforms, they generally tend to pick up aromatic traits from other plants more easily. But there are certain aromatic traits—Banana OG is a really great example where there’s almost a standard banana-type smell, green banana-type smell and then the overripe, sugary, almost candied banana smell. Those three smells, while you get variation between the three, they’re very fleeting. When you breed it against other things, there are only very few strains that seem to be able to be bred against it.

The same thing happens when you breed it against itself, depending on how stable it is and depending on which plant shows which expression. So, yes, some strains do more of that and some strains do less of that. The thing that is true of all breeding, especially with where we are in the plant’s life, is that they are all fragile to some degree, if you’re not being mindful about making the selections and doing your due diligence in the field. Even just the wrong selection can lead to you losing an incredible aroma profile or something else that you might’ve found interesting.

ES: What’s the bar that you’re trying to clear with these genetics? Meaning, what does it take for a certain stable line to make the cut and get out into the consumer marketplace?

KA: The biggest thing is plant health, obviously. The plant has to be healthy throughout its whole life. We don’t look to plants that are weak in the beginning of their life. From there, it’s mostly on the aromatic qualities and the quality of the oil production. And when I say the quality, obviously with the aromatics it’s more a desirability factor. With cannabis, that can come across as a lot of different notes. Some people like the skunk, the funk, the dank. Other people are looking particularly toward fruity flavors or things that are more familiar to them—things like lemons or orange or berry. If we think that it meets any one of multiple criteria for what we think is good aroma, that’s one of the bigger drivers for moving it forward.

As far as good oil production, obviously if we’re going to keep the genetics moving forward we’d like something that’s abundant in resins. But also what we’re looking for is stuff that just produces good resin heads and abundant production of terpene so that we can collect those more readily. As long as it’s smells good and it’s producing a fair amount of oil, we generally push it through and then let the consumers to some degree provide feedback based on sell-through and other metrics. What we do if some things get moved forward into the market and there’s less of a response, those things never end up coming back. With other things, if we see a huge groundswell of support, we’ll know early on to try and refocus energies around that.

There’s a lot of hedging and making our own guesses on what we think will be popular. Like fashion, what’s trendy in the cannabis space seems to be cyclical. Anything that was popular a couple of years ago could likely be popular a few years into the future. Same with novelty. Where we have certain strains today, it’s very likely that we’ll have new strains with new aromatic qualities that we’ve never even thought of in a few years.

Brian Walker/Courtesy of Raw Garden

ES: You mentioned resin content, but are there certain traits or certain types of traits that end up making a cultivar or a family of cultivars better suited for the concentrates/vape form as opposed to just straight flower?

KA: Structure is a big one, as well as mold resistance and insect resistance. This goes back to the health of the plant. Mold resistance, in particular, and bug resistance are traits that the plants pick up—and these aren’t just passive traits. They have more to do with things like terpene and oil production. More resinous plants with certain volatile, aromatic compounds tend to repel bugs. Similarly, good structure and the right kind of spacing and not overly leafy plants act as better barriers to moisture, which subsequently results in more mold resistance. The thing that’s kind of funny, and I don’t know if it’s a term everyone recognizes, but we generally refer to buds that are kind of large and oversized as larfy, and they’re considered undesirable.

It refers to poor structure. Those kinds of larfier, bigger buds that don’t have great bag appeal for a finished flower, but their calyx structure is slightly more open and they have a more resinous appearance than their bagged flower counterpart, those are actually one of the more desirable traits that we try and look for. It’s not the most important, as we really are looking at aromatics and oil production as the most important, but these structural differences where they would be completely undesirable with bagged flower actually allow for more surface area for the extraction process. They’re just great plants to extract against or to make hash with. We do look for tighter structure and better calyx separation for different kinds of buds for plant health, especially in the breeding program. We produce all of our seeds in-house, so plants that don’t have too much leaf on them make less work for the field team.

ES: Looking at the strains list on the Raw Garden website, of course, there’s are a lot on here that are very well established—some crosses and familiar names. But as these unique strains are being created by Raw Garden, how do the naming conventions work?

KA: We do a lot of strains that are very well-known and pre-existing, but even with those strains we generally work on inbred lines. We’ll take, say, a Gorilla Glue female and another Gorilla Glue female, and we’ll turn one of those into a pollinating plant and then breed that back against the Gorilla Glue females so that we can produce seeds from it. Depending on the stability of the genetics, it just starts the whole process of selection. Less secure genetics or less well-defined genetics will generally tend to range and require a lot more selection. If we’re moving forward genetics, especially in the inbred fashion from people that have done some of the work already, we like to keep those names as close to that as possible.

I only mention that because it does feed into the rest of the naming convention. So, obviously, if it comes from an inbred line and it’s reflective of something in the market, we call it that name. If it’s something from an inbred line that throws something completely random that is not reflective of what’s in the market, we usually look to a name that somehow calls out the parentage or shows an association with that parentage.

From there, as we go out into cross-breeding and other things, it depends on how many times the plant’s been worked. If the plant is in an early iteration of being crossed, we generally look for names inside of that strain’s name and use parental naming constructs to come up with a name. Maybe Purple Punch and Jack Herer would become Jack Punch. But say that we’ve bred Jack Herer and Purple Punch together multiple times, and from the Jack Punch and the Jack Herer we get something that tastes completely different, that may become something derivative where we get into the world of maybe a little bit more fun—or we try and play off the name that we came to from that parental construct.

The other thing that’s cool is when the plants are very similar but we think that there’s just slight variation, we do what most breeders do, which is we just add a number. Even GG4 is just a reflection of someone’s favorite cut. 

When we get further out on generational stuff and we’re more into the weeds and we’re in places where maybe we’ve got five or six things crossing back against three other things, we generally tend to kind of lean on three different pillars.

If it has a very distinct taste that our team can smell and call out, we generally like to use some sort of flavor descriptor to be a clear indicator to people that this is going to have some amount of citrus or cherry or berry. I’m very particular that it has to be apparent. You have to be able to smell it and feel like it’s there in order for us to use the clear flavor descriptor in the naming. If that doesn’t work—if we feel like the flavor is distinct and interesting, but maybe hard to put your finger on—then we started going to kind of more experience or emotional type of thing. We try and think of the energy of the experience. If it’s a really fruity kind of light, fun smell, then maybe we’re going to call it Island Splash or Tropical Mist or something that feels like it calls out the energy and the flavors that we’re tasting.

The last one, which I would say probably makes up less than 5% of our strains, is just the completely random thing that isn’t necessarily driven off of anything, but we just think that this tastes so amazing and that this is such a rare unicorm that we’ve got to come up with something cooler than just smashing mom and dad’s names together. It’s just that special and that impactful, and we’ll come up with a fun name, like Pink Pegasus or something to that degree, which we just think has a lot of fun energy.

ES: Looking ahead to the summer, is there anything in particular that might be new coming up at Raw Garden or anything that you’d want to highlight?

KA: We’ve just released our crushed diamonds, which are just a phenomenal opportunity for people to try our concentrates and our wide array of aromatics and flavors. It’s a THCA isolate. The crushed diamonds have perfume-quality terpenes from our live resin extract. You get this beautiful aromatic experience. You can sprinkle it on a joint if you’re not really a dabber, or you can throw it on top of a bowl, or you can dab it the traditional way.

Some of the strains that we have coming, like our Wedding Breath—or one of my favorites that we’ve had for a while now, that’s really gotten stabilized, is our Funk N Fire, which is Leroy OG, which is a nice gassy strain and then Gorilla Glue 4, which has that chemical solvent taste, and you mix the two together and it’s just like all funk and gas. For me, it’s a really great representation of those heritage aromas that we like.

We’ve got one coming that doesn’t have a name yet, and so we’ll let the hype build a little bit behind it, but it has notes of black licorice or anise. The plant has this limitless capacity to surprise. Every year, we keep finding aromas that we didn’t expect.

 

On Raw Garden’s website, as of May 2021, the Santa Barbara-based cannabis cultivation business lists “839 strains and counting,” each one an example of the breeding program at the heart of the garden. From Abracadabra to Zookies, the sheer variety taps into one of the great forces in the cannabis consumer marketplace: a search for something new.

We spoke with Raw Garden’s product director, Khalid Al-Naser, to learn more about the strategy.

Eric Sandy: Could you describe how Raw Garden came to be?

Khalid Al-Naser: I’ve been with Raw Garden through every iteration, which started in the [Prop.] 215 space. A lot of the early culture and ethos was built around the idea of developing good medicine: quality, consistently, at an accessible price. As we moved through a lot of the transition [to the adult-use market] and licensing, we really tried to keep that at the heart of what we were doing.

So, we pushed really hard around the concentrates. As the 30% tax came in, we lowered our price to make sure that consumers didn’t have a price change at the retail level. Subsequently, we ended up launching our vape carts, which just put us in a really great position in the market. We were priced well and had a high-quality product, which just made a really great value proposition. That really pushed us along to where we are today, which is a growing brand that’s really trying to provide a lot of great consumer experiences—while still holding onto this idea that we can create accessible products that are high-quality, and it doesn’t have to be stagnant or boring.

Courtesy of Raw Garden

ES: Breeding is a big part of that mission, right? Making sure that the product line is not stagnant?

KA: In our earlier iterations, we did indoor growing. So, as we transitioned in 2015 to the farm and took the name Raw Garden, Thomas Martin and John De Friel, who founded the farm along with two others, invested really early into breeding. The idea of quality was really emphasized by the need to control the supply chain. They understood that the cloning process and a lot of the things that were being done in that industry didn’t support good agronomics.

Early on, there was a lot of investment there, as a consequence of that striving for accessibility and quality. The only way we can make it accessible is by exploiting efficiencies, which is what farmers traditionally do. And then the high quality really comes from that ability to control the farmed product, rather than having somebody else to it for you.

ES: What does an in-house breeding program allow Raw Garden to do when it comes to interacting with the customer or responding to customer sales trends?

KA: The really cool thing about it is that it almost allots you every opportunity—albeit at a huge expense, mostly in time and energy. What we do is try and follow consumer trends and breed for things that are popular, but we also hedge our bets and utilize our program as an opportunity to hold on to legacy strains or heritage strains that we feel are important things that people will want to come back to. It allows us the ability to plant seeds rather than clones. That allows for an amazing efficiency, not only from a business perspective, but also just in the plants’ production or productiveness. When we plant seeds, we get a good, strong taproot. The subsequent benefits of that are a much more vigorous plant. With clones, oftentimes you get a very repeatable product, but there are sensitivities around when the cutting is taken and the quality of the cutting.

By breeding, we’re really trying to breed for farmable seed that are semi-homogenous, if not homogenous. They give us repeatable aromatic bouquets, but also repeatable agronomic traits that make it easier to farm and easier to harvest. When I say easier to harvest, the uniformity of the crop allows for uniform maturation, which means that you can uniformly harvest. When you have a lot of the variation, so too is there variation in the maturity. So that becomes a big issue.

The biggest thing that it allows us is to drive diversity and assortment. If you think about it, most cannabis producers, especially on a smaller scale, ourselves included at many parts of our iterative cycles, rely on clones.

Clones are really when somebody is taking a bag of seeds and planting them, it’s their favorite plant or the plant that performed or smelled or looked the best to them. So, they select that plant and they make cuttings from it. As a consequence, they end up with a very uniform plant that is needing to be managed in order to keep it in and continue to move forward its progeny. But when you planted those seeds, there were less desirable or different strains that were not selected against for whichever reason. What we find a lot of times nowadays with better genetics is that sometimes breeders will have more than one favorite out of a bag of seeds.

ES: The possibilities seem immense.

KA: A great example is that we were known early on for our Slymer strain, which is an F1 phenotype from Chernobyl, which is from Subcool seeds. They would acknowledge that they have what they would call the Golden Ticket, which was this Slymer phenotype, which for Chernobyl is generally a lemon/chem type of flavor. The Slymer was a very clear lime flavor. So, both of these things were coming out of the same seed line, and it just really depended which expression you got. Similarly, when we’re breeding, back-breeding or crossing different strains, sometimes we’ll get more than one variation that we find desirable. Sometimes we’ll even get recessive traits that will just kind of pop out that are unique and new and interesting from that seed line.

What we do is we make those selections and then we start breeding against those multiple different lines. And that ability to follow what we think is agronomically interesting, as well as what smells interesting and looks like it’ll be an impactful plant, is the consequence of variety. From everything we plant, we end up with anywhere from maybe one to five varieties, depending on where it is in regards to breeding. As we stabilize those individual things, they become an individual particular strain, but maybe earlier on generationally, there was a point where they branched off into three different strains.

ES: How fragile are these genetic lines? If you’re not dialed in as a breeder, is it possible to lose some of the traits that you’re actually trying to select for?

KA: Like all genetic traits, you have dominant and recessive traits. And I won’t suggest to say we know enough about plant yet to say definitively, but it seems like some plants act as better platforms. A lot of times, those are agronomic traits—the structure of the plant, the shape of the plant, the shape of the bud. When we find those good platforms, they generally tend to pick up aromatic traits from other plants more easily. But there are certain aromatic traits—Banana OG is a really great example where there’s almost a standard banana-type smell, green banana-type smell and then the overripe, sugary, almost candied banana smell. Those three smells, while you get variation between the three, they’re very fleeting. When you breed it against other things, there are only very few strains that seem to be able to be bred against it.

The same thing happens when you breed it against itself, depending on how stable it is and depending on which plant shows which expression. So, yes, some strains do more of that and some strains do less of that. The thing that is true of all breeding, especially with where we are in the plant’s life, is that they are all fragile to some degree, if you’re not being mindful about making the selections and doing your due diligence in the field. Even just the wrong selection can lead to you losing an incredible aroma profile or something else that you might’ve found interesting.

ES: What’s the bar that you’re trying to clear with these genetics? Meaning, what does it take for a certain stable line to make the cut and get out into the consumer marketplace?

KA: The biggest thing is plant health, obviously. The plant has to be healthy throughout its whole life. We don’t look to plants that are weak in the beginning of their life. From there, it’s mostly on the aromatic qualities and the quality of the oil production. And when I say the quality, obviously with the aromatics it’s more a desirability factor. With cannabis, that can come across as a lot of different notes. Some people like the skunk, the funk, the dank. Other people are looking particularly toward fruity flavors or things that are more familiar to them—things like lemons or orange or berry. If we think that it meets any one of multiple criteria for what we think is good aroma, that’s one of the bigger drivers for moving it forward.

As far as good oil production, obviously if we’re going to keep the genetics moving forward we’d like something that’s abundant in resins. But also what we’re looking for is stuff that just produces good resin heads and abundant production of terpene so that we can collect those more readily. As long as it’s smells good and it’s producing a fair amount of oil, we generally push it through and then let the consumers to some degree provide feedback based on sell-through and other metrics. What we do if some things get moved forward into the market and there’s less of a response, those things never end up coming back. With other things, if we see a huge groundswell of support, we’ll know early on to try and refocus energies around that.

There’s a lot of hedging and making our own guesses on what we think will be popular. Like fashion, what’s trendy in the cannabis space seems to be cyclical. Anything that was popular a couple of years ago could likely be popular a few years into the future. Same with novelty. Where we have certain strains today, it’s very likely that we’ll have new strains with new aromatic qualities that we’ve never even thought of in a few years.

Brian Walker/Courtesy of Raw Garden

ES: You mentioned resin content, but are there certain traits or certain types of traits that end up making a cultivar or a family of cultivars better suited for the concentrates/vape form as opposed to just straight flower?

KA: Structure is a big one, as well as mold resistance and insect resistance. This goes back to the health of the plant. Mold resistance, in particular, and bug resistance are traits that the plants pick up—and these aren’t just passive traits. They have more to do with things like terpene and oil production. More resinous plants with certain volatile, aromatic compounds tend to repel bugs. Similarly, good structure and the right kind of spacing and not overly leafy plants act as better barriers to moisture, which subsequently results in more mold resistance. The thing that’s kind of funny, and I don’t know if it’s a term everyone recognizes, but we generally refer to buds that are kind of large and oversized as larfy, and they’re considered undesirable.

It refers to poor structure. Those kinds of larfier, bigger buds that don’t have great bag appeal for a finished flower, but their calyx structure is slightly more open and they have a more resinous appearance than their bagged flower counterpart, those are actually one of the more desirable traits that we try and look for. It’s not the most important, as we really are looking at aromatics and oil production as the most important, but these structural differences where they would be completely undesirable with bagged flower actually allow for more surface area for the extraction process. They’re just great plants to extract against or to make hash with. We do look for tighter structure and better calyx separation for different kinds of buds for plant health, especially in the breeding program. We produce all of our seeds in-house, so plants that don’t have too much leaf on them make less work for the field team.

ES: Looking at the strains list on the Raw Garden website, of course, there’s are a lot on here that are very well established—some crosses and familiar names. But as these unique strains are being created by Raw Garden, how do the naming conventions work?

KA: We do a lot of strains that are very well-known and pre-existing, but even with those strains we generally work on inbred lines. We’ll take, say, a Gorilla Glue female and another Gorilla Glue female, and we’ll turn one of those into a pollinating plant and then breed that back against the Gorilla Glue females so that we can produce seeds from it. Depending on the stability of the genetics, it just starts the whole process of selection. Less secure genetics or less well-defined genetics will generally tend to range and require a lot more selection. If we’re moving forward genetics, especially in the inbred fashion from people that have done some of the work already, we like to keep those names as close to that as possible.

I only mention that because it does feed into the rest of the naming convention. So, obviously, if it comes from an inbred line and it’s reflective of something in the market, we call it that name. If it’s something from an inbred line that throws something completely random that is not reflective of what’s in the market, we usually look to a name that somehow calls out the parentage or shows an association with that parentage.

From there, as we go out into cross-breeding and other things, it depends on how many times the plant’s been worked. If the plant is in an early iteration of being crossed, we generally look for names inside of that strain’s name and use parental naming constructs to come up with a name. Maybe Purple Punch and Jack Herer would become Jack Punch. But say that we’ve bred Jack Herer and Purple Punch together multiple times, and from the Jack Punch and the Jack Herer we get something that tastes completely different, that may become something derivative where we get into the world of maybe a little bit more fun—or we try and play off the name that we came to from that parental construct.

The other thing that’s cool is when the plants are very similar but we think that there’s just slight variation, we do what most breeders do, which is we just add a number. Even GG4 is just a reflection of someone’s favorite cut. 

When we get further out on generational stuff and we’re more into the weeds and we’re in places where maybe we’ve got five or six things crossing back against three other things, we generally tend to kind of lean on three different pillars.

If it has a very distinct taste that our team can smell and call out, we generally like to use some sort of flavor descriptor to be a clear indicator to people that this is going to have some amount of citrus or cherry or berry. I’m very particular that it has to be apparent. You have to be able to smell it and feel like it’s there in order for us to use the clear flavor descriptor in the naming. If that doesn’t work—if we feel like the flavor is distinct and interesting, but maybe hard to put your finger on—then we started going to kind of more experience or emotional type of thing. We try and think of the energy of the experience. If it’s a really fruity kind of light, fun smell, then maybe we’re going to call it Island Splash or Tropical Mist or something that feels like it calls out the energy and the flavors that we’re tasting.

The last one, which I would say probably makes up less than 5% of our strains, is just the completely random thing that isn’t necessarily driven off of anything, but we just think that this tastes so amazing and that this is such a rare unicorm that we’ve got to come up with something cooler than just smashing mom and dad’s names together. It’s just that special and that impactful, and we’ll come up with a fun name, like Pink Pegasus or something to that degree, which we just think has a lot of fun energy.

ES: Looking ahead to the summer, is there anything in particular that might be new coming up at Raw Garden or anything that you’d want to highlight?

KA: We’ve just released our crushed diamonds, which are just a phenomenal opportunity for people to try our concentrates and our wide array of aromatics and flavors. It’s a THCA isolate. The crushed diamonds have perfume-quality terpenes from our live resin extract. You get this beautiful aromatic experience. You can sprinkle it on a joint if you’re not really a dabber, or you can throw it on top of a bowl, or you can dab it the traditional way.

Some of the strains that we have coming, like our Wedding Breath—or one of my favorites that we’ve had for a while now, that’s really gotten stabilized, is our Funk N Fire, which is Leroy OG, which is a nice gassy strain and then Gorilla Glue 4, which has that chemical solvent taste, and you mix the two together and it’s just like all funk and gas. For me, it’s a really great representation of those heritage aromas that we like.

We’ve got one coming that doesn’t have a name yet, and so we’ll let the hype build a little bit behind it, but it has notes of black licorice or anise. The plant has this limitless capacity to surprise. Every year, we keep finding aromas that we didn’t expect.

 

On Raw Garden’s website, as of May 2021, the Santa Barbara-based cannabis cultivation business lists “839 strains and counting,” each one an example of the breeding program at the heart of the garden. From Abracadabra to Zookies, the sheer variety taps into one of the great forces in the cannabis consumer marketplace: a search for something new.

We spoke with Raw Garden’s product director, Khalid Al-Naser, to learn more about the strategy.

Eric Sandy: Could you describe how Raw Garden came to be?

Khalid Al-Naser: I’ve been with Raw Garden through every iteration, which started in the [Prop.] 215 space. A lot of the early culture and ethos was built around the idea of developing good medicine: quality, consistently, at an accessible price. As we moved through a lot of the transition [to the adult-use market] and licensing, we really tried to keep that at the heart of what we were doing.

So, we pushed really hard around the concentrates. As the 30% tax came in, we lowered our price to make sure that consumers didn’t have a price change at the retail level. Subsequently, we ended up launching our vape carts, which just put us in a really great position in the market. We were priced well and had a high-quality product, which just made a really great value proposition. That really pushed us along to where we are today, which is a growing brand that’s really trying to provide a lot of great consumer experiences—while still holding onto this idea that we can create accessible products that are high-quality, and it doesn’t have to be stagnant or boring.

Courtesy of Raw Garden

ES: Breeding is a big part of that mission, right? Making sure that the product line is not stagnant?

KA: In our earlier iterations, we did indoor growing. So, as we transitioned in 2015 to the farm and took the name Raw Garden, Thomas Martin and John De Friel, who founded the farm along with two others, invested really early into breeding. The idea of quality was really emphasized by the need to control the supply chain. They understood that the cloning process and a lot of the things that were being done in that industry didn’t support good agronomics.

Early on, there was a lot of investment there, as a consequence of that striving for accessibility and quality. The only way we can make it accessible is by exploiting efficiencies, which is what farmers traditionally do. And then the high quality really comes from that ability to control the farmed product, rather than having somebody else to it for you.

ES: What does an in-house breeding program allow Raw Garden to do when it comes to interacting with the customer or responding to customer sales trends?

KA: The really cool thing about it is that it almost allots you every opportunity—albeit at a huge expense, mostly in time and energy. What we do is try and follow consumer trends and breed for things that are popular, but we also hedge our bets and utilize our program as an opportunity to hold on to legacy strains or heritage strains that we feel are important things that people will want to come back to. It allows us the ability to plant seeds rather than clones. That allows for an amazing efficiency, not only from a business perspective, but also just in the plants’ production or productiveness. When we plant seeds, we get a good, strong taproot. The subsequent benefits of that are a much more vigorous plant. With clones, oftentimes you get a very repeatable product, but there are sensitivities around when the cutting is taken and the quality of the cutting.

By breeding, we’re really trying to breed for farmable seed that are semi-homogenous, if not homogenous. They give us repeatable aromatic bouquets, but also repeatable agronomic traits that make it easier to farm and easier to harvest. When I say easier to harvest, the uniformity of the crop allows for uniform maturation, which means that you can uniformly harvest. When you have a lot of the variation, so too is there variation in the maturity. So that becomes a big issue.

The biggest thing that it allows us is to drive diversity and assortment. If you think about it, most cannabis producers, especially on a smaller scale, ourselves included at many parts of our iterative cycles, rely on clones.

Clones are really when somebody is taking a bag of seeds and planting them, it’s their favorite plant or the plant that performed or smelled or looked the best to them. So, they select that plant and they make cuttings from it. As a consequence, they end up with a very uniform plant that is needing to be managed in order to keep it in and continue to move forward its progeny. But when you planted those seeds, there were less desirable or different strains that were not selected against for whichever reason. What we find a lot of times nowadays with better genetics is that sometimes breeders will have more than one favorite out of a bag of seeds.

ES: The possibilities seem immense.

KA: A great example is that we were known early on for our Slymer strain, which is an F1 phenotype from Chernobyl, which is from Subcool seeds. They would acknowledge that they have what they would call the Golden Ticket, which was this Slymer phenotype, which for Chernobyl is generally a lemon/chem type of flavor. The Slymer was a very clear lime flavor. So, both of these things were coming out of the same seed line, and it just really depended which expression you got. Similarly, when we’re breeding, back-breeding or crossing different strains, sometimes we’ll get more than one variation that we find desirable. Sometimes we’ll even get recessive traits that will just kind of pop out that are unique and new and interesting from that seed line.

What we do is we make those selections and then we start breeding against those multiple different lines. And that ability to follow what we think is agronomically interesting, as well as what smells interesting and looks like it’ll be an impactful plant, is the consequence of variety. From everything we plant, we end up with anywhere from maybe one to five varieties, depending on where it is in regards to breeding. As we stabilize those individual things, they become an individual particular strain, but maybe earlier on generationally, there was a point where they branched off into three different strains.

ES: How fragile are these genetic lines? If you’re not dialed in as a breeder, is it possible to lose some of the traits that you’re actually trying to select for?

KA: Like all genetic traits, you have dominant and recessive traits. And I won’t suggest to say we know enough about plant yet to say definitively, but it seems like some plants act as better platforms. A lot of times, those are agronomic traits—the structure of the plant, the shape of the plant, the shape of the bud. When we find those good platforms, they generally tend to pick up aromatic traits from other plants more easily. But there are certain aromatic traits—Banana OG is a really great example where there’s almost a standard banana-type smell, green banana-type smell and then the overripe, sugary, almost candied banana smell. Those three smells, while you get variation between the three, they’re very fleeting. When you breed it against other things, there are only very few strains that seem to be able to be bred against it.

The same thing happens when you breed it against itself, depending on how stable it is and depending on which plant shows which expression. So, yes, some strains do more of that and some strains do less of that. The thing that is true of all breeding, especially with where we are in the plant’s life, is that they are all fragile to some degree, if you’re not being mindful about making the selections and doing your due diligence in the field. Even just the wrong selection can lead to you losing an incredible aroma profile or something else that you might’ve found interesting.

ES: What’s the bar that you’re trying to clear with these genetics? Meaning, what does it take for a certain stable line to make the cut and get out into the consumer marketplace?

KA: The biggest thing is plant health, obviously. The plant has to be healthy throughout its whole life. We don’t look to plants that are weak in the beginning of their life. From there, it’s mostly on the aromatic qualities and the quality of the oil production. And when I say the quality, obviously with the aromatics it’s more a desirability factor. With cannabis, that can come across as a lot of different notes. Some people like the skunk, the funk, the dank. Other people are looking particularly toward fruity flavors or things that are more familiar to them—things like lemons or orange or berry. If we think that it meets any one of multiple criteria for what we think is good aroma, that’s one of the bigger drivers for moving it forward.

As far as good oil production, obviously if we’re going to keep the genetics moving forward we’d like something that’s abundant in resins. But also what we’re looking for is stuff that just produces good resin heads and abundant production of terpene so that we can collect those more readily. As long as it’s smells good and it’s producing a fair amount of oil, we generally push it through and then let the consumers to some degree provide feedback based on sell-through and other metrics. What we do if some things get moved forward into the market and there’s less of a response, those things never end up coming back. With other things, if we see a huge groundswell of support, we’ll know early on to try and refocus energies around that.

There’s a lot of hedging and making our own guesses on what we think will be popular. Like fashion, what’s trendy in the cannabis space seems to be cyclical. Anything that was popular a couple of years ago could likely be popular a few years into the future. Same with novelty. Where we have certain strains today, it’s very likely that we’ll have new strains with new aromatic qualities that we’ve never even thought of in a few years.

Brian Walker/Courtesy of Raw Garden

ES: You mentioned resin content, but are there certain traits or certain types of traits that end up making a cultivar or a family of cultivars better suited for the concentrates/vape form as opposed to just straight flower?

KA: Structure is a big one, as well as mold resistance and insect resistance. This goes back to the health of the plant. Mold resistance, in particular, and bug resistance are traits that the plants pick up—and these aren’t just passive traits. They have more to do with things like terpene and oil production. More resinous plants with certain volatile, aromatic compounds tend to repel bugs. Similarly, good structure and the right kind of spacing and not overly leafy plants act as better barriers to moisture, which subsequently results in more mold resistance. The thing that’s kind of funny, and I don’t know if it’s a term everyone recognizes, but we generally refer to buds that are kind of large and oversized as larfy, and they’re considered undesirable.

It refers to poor structure. Those kinds of larfier, bigger buds that don’t have great bag appeal for a finished flower, but their calyx structure is slightly more open and they have a more resinous appearance than their bagged flower counterpart, those are actually one of the more desirable traits that we try and look for. It’s not the most important, as we really are looking at aromatics and oil production as the most important, but these structural differences where they would be completely undesirable with bagged flower actually allow for more surface area for the extraction process. They’re just great plants to extract against or to make hash with. We do look for tighter structure and better calyx separation for different kinds of buds for plant health, especially in the breeding program. We produce all of our seeds in-house, so plants that don’t have too much leaf on them make less work for the field team.

ES: Looking at the strains list on the Raw Garden website, of course, there’s are a lot on here that are very well established—some crosses and familiar names. But as these unique strains are being created by Raw Garden, how do the naming conventions work?

KA: We do a lot of strains that are very well-known and pre-existing, but even with those strains we generally work on inbred lines. We’ll take, say, a Gorilla Glue female and another Gorilla Glue female, and we’ll turn one of those into a pollinating plant and then breed that back against the Gorilla Glue females so that we can produce seeds from it. Depending on the stability of the genetics, it just starts the whole process of selection. Less secure genetics or less well-defined genetics will generally tend to range and require a lot more selection. If we’re moving forward genetics, especially in the inbred fashion from people that have done some of the work already, we like to keep those names as close to that as possible.

I only mention that because it does feed into the rest of the naming convention. So, obviously, if it comes from an inbred line and it’s reflective of something in the market, we call it that name. If it’s something from an inbred line that throws something completely random that is not reflective of what’s in the market, we usually look to a name that somehow calls out the parentage or shows an association with that parentage.

From there, as we go out into cross-breeding and other things, it depends on how many times the plant’s been worked. If the plant is in an early iteration of being crossed, we generally look for names inside of that strain’s name and use parental naming constructs to come up with a name. Maybe Purple Punch and Jack Herer would become Jack Punch. But say that we’ve bred Jack Herer and Purple Punch together multiple times, and from the Jack Punch and the Jack Herer we get something that tastes completely different, that may become something derivative where we get into the world of maybe a little bit more fun—or we try and play off the name that we came to from that parental construct.

The other thing that’s cool is when the plants are very similar but we think that there’s just slight variation, we do what most breeders do, which is we just add a number. Even GG4 is just a reflection of someone’s favorite cut. 

When we get further out on generational stuff and we’re more into the weeds and we’re in places where maybe we’ve got five or six things crossing back against three other things, we generally tend to kind of lean on three different pillars.

If it has a very distinct taste that our team can smell and call out, we generally like to use some sort of flavor descriptor to be a clear indicator to people that this is going to have some amount of citrus or cherry or berry. I’m very particular that it has to be apparent. You have to be able to smell it and feel like it’s there in order for us to use the clear flavor descriptor in the naming. If that doesn’t work—if we feel like the flavor is distinct and interesting, but maybe hard to put your finger on—then we started going to kind of more experience or emotional type of thing. We try and think of the energy of the experience. If it’s a really fruity kind of light, fun smell, then maybe we’re going to call it Island Splash or Tropical Mist or something that feels like it calls out the energy and the flavors that we’re tasting.

The last one, which I would say probably makes up less than 5% of our strains, is just the completely random thing that isn’t necessarily driven off of anything, but we just think that this tastes so amazing and that this is such a rare unicorm that we’ve got to come up with something cooler than just smashing mom and dad’s names together. It’s just that special and that impactful, and we’ll come up with a fun name, like Pink Pegasus or something to that degree, which we just think has a lot of fun energy.

ES: Looking ahead to the summer, is there anything in particular that might be new coming up at Raw Garden or anything that you’d want to highlight?

KA: We’ve just released our crushed diamonds, which are just a phenomenal opportunity for people to try our concentrates and our wide array of aromatics and flavors. It’s a THCA isolate. The crushed diamonds have perfume-quality terpenes from our live resin extract. You get this beautiful aromatic experience. You can sprinkle it on a joint if you’re not really a dabber, or you can throw it on top of a bowl, or you can dab it the traditional way.

Some of the strains that we have coming, like our Wedding Breath—or one of my favorites that we’ve had for a while now, that’s really gotten stabilized, is our Funk N Fire, which is Leroy OG, which is a nice gassy strain and then Gorilla Glue 4, which has that chemical solvent taste, and you mix the two together and it’s just like all funk and gas. For me, it’s a really great representation of those heritage aromas that we like.

We’ve got one coming that doesn’t have a name yet, and so we’ll let the hype build a little bit behind it, but it has notes of black licorice or anise. The plant has this limitless capacity to surprise. Every year, we keep finding aromas that we didn’t expect.

 

Washington, D.C., is best known as a Congressional battleground, the stage for legislative developments that impact the country.

But beyond the new iron fences around the Capitol, the District itself is a vibrant city full of culture and ethnic history. And thanks to centuries-old laws that give Congress broad oversight over the capital, it’s home to the most unique cannabis industry structure in the nation: Despite it being legal to possess and even grow at home, it’s been against the law to sell cannabis in D.C. since legalization took effect six years ago.

Yet industry activists and stakeholders believe change is imminent, now that the White House has a new occupant and the Senate is controlled by Democrats. The D.C. government appears to agree: According to officials, preparation is already underway for local licensing and regulation of adult-use cannabis sales. 

Cannabis Business Times and Cannabis Dispensary spoke to experts in the D.C. cannabis scene about how the new industry should be regulated and the most probable path to establishing adult-use sales in the District.

What’s the current status of cannabis in D.C.?

D.C. legalized cannabis with its Initiative 71, which passed in 2014 and went into effect in February 2015. The new law allowed adult residents to possess up to two ounces of cannabis, grow up to six plants at home and consume on private property. Residents are also allowed to “gift” someone up to an ounce, but sales of any amount are prohibited thanks to the infamous “Harris Rider,” a provision blocking D.C. cannabis sales which for years was added onto the federal budget by Rep. Andy Harris (R-MD). 

The prohibition on sales has created an industry of discrete “pop-up” marketplaces, often staged at a private residence or other location revealed only to attendees. Though these underground “dispensaries” are often heavily-guarded, they are also frequent targets of police raids and violent crime, particularly robbery, since perpetrators know vendors are in a legal grey area and unlikely to call the police or report the incident.

Recent movement on D.C. cannabis sales

Early in 2021, the government moved to rectify the situation through local legislation. Two separate bills have been introduced: Mayor Muriel Bowser’s Safe Cannabis Sales Act of 2021, and Councilmember Phil Mendelson’s Comprehensive Cannabis Legalization and Regulation Act of 2021. 

The bills are similar but contain some important differences. Mayor Bowser’s bill sets specific caps on the amount of revenue to be put towards community grants and business startup assistance, while Councilman Mendelson’s bill devotes 50% of cannabis revenue into a Community Reinvestment Fund and 30% into a Social Equity Fund to provide loans and assistance to social equity license applicants. The Mayor’s bill also limits license types to just five kinds, although both bills create microbusiness license categories. Bowser’s bill also has a higher tax rate at 17%, compared to 13% in Mendelson’s proposal.

Comparing bills and predicting the future

Activists seem to have a clear preference for Councilmember Mendelson’s plan.

“The mayor’s bill doesn’t even deserve to be taken seriously,” said Adam Eidinger, founder of advocacy group DC Marijuana Justice and an integral figure in the passing of Initiative 71 in the District. 

Eidinger told Cannabis Business Times and Cannabis Dispensary that Bowser’s bill would effectively end homegrow, an important provision in legalization bills that provides for equitable access to cannabis.

“It has a ten-ounce rule. … You can’t have more than ten ounces of cannabis in your house under her bill,” added Eidinger. “Why is that even in there? It’s in there to enrich the corporate establishment that doesn’t like home cultivation.”

Eidinger argued that any legalization bill should go the opposite direction and raise or remove the current six-plant limit. He stressed that the District would be best served by the creation of a “cottage industry” for cannabis, similar to craft beer or produce.

“We’re going to the councilmembers systematically and we’re asking them, ‘Have you considered casual sales first? Have you considered farmers’ markets and giving home growers a lawful way to sell their cannabis?’” said Eidinger. 

“What we’re not fighting for is a closed, high-barrier to entry [industry with] limited numbers of licenses for cultivators and sellers. We would rather see the free market roll. … Let the chips fall where they may and the best companies rise to the top. … I think we can get a cottage industry here—we are really suited for it.”

In March, the Drug Policy Alliance also released a statement expressing preference for Councilman Mendelson’s bill.

Morgan Fox, media relations director for the National Cannabis Industry Association, which has offices in the District, agreed that cannabis sales will likely be allowed in D.C. sooner rather than late—possibly even before federal movement on cannabis.

“I think that the chances of Congress passing an appropriations bill that omits the Harris rider are much greater this year than the chances of Congress descheduling cannabis,” said Fox via email. “Given that Mayor Bowser has publicly stated that DC regulators are already preparing for the passage of either regulatory bill before the Council, I’d say the probability of DC regulating cannabis before the federal government starts that process is fairly high.”

What about statehood?

Some believe that D.C. might need to first achieve statehood to shirk the restrictions imposed by Congress. H.R. 51, a resolution to turn the residential and commercial parts of the District into the country’s 51st state, passed in the House last month.

But with a razor-thin Democratic margin in the Senate and moderate Sen. Joe Manchin (D-WV) publicly announcing his opposition to the proposal, D.C. doesn’t currently have a realistic path to statehood.

“I’m pretty pessimistic about statehood at this point,” said Eidinger. “The real assessment of it is that people like Joe Manchin are standing in the way of it.” Fox also agreed that D.C. was likely to pass a bill regulating cannabis sales before the government granting statehood to the District.

That means it’s likely to come down to legislators, activists and constituents in D.C. to create the kind of equitable cannabis industry that the District of Columbia—with its rich history of Black and brown prosperity—deserves.

Washington, D.C., is best known as a Congressional battleground, the stage for legislative developments that impact the country.

But beyond the new iron fences around the Capitol, the District itself is a vibrant city full of culture and ethnic history. And thanks to centuries-old laws that give Congress broad oversight over the capital, it’s home to the most unique cannabis industry structure in the nation: Despite it being legal to possess and even grow at home, it’s been against the law to sell cannabis in D.C. since legalization took effect six years ago.

Yet industry activists and stakeholders believe change is imminent, now that the White House has a new occupant and the Senate is controlled by Democrats. The D.C. government appears to agree: According to officials, preparation is already underway for local licensing and regulation of adult-use cannabis sales. 

Cannabis Business Times and Cannabis Dispensary spoke to experts in the D.C. cannabis scene about how the new industry should be regulated and the most probable path to establishing adult-use sales in the District.

What’s the current status of cannabis in D.C.?

D.C. legalized cannabis with its Initiative 71, which passed in 2014 and went into effect in February 2015. The new law allowed adult residents to possess up to two ounces of cannabis, grow up to six plants at home and consume on private property. Residents are also allowed to “gift” someone up to an ounce, but sales of any amount are prohibited thanks to the infamous “Harris Rider,” a provision blocking D.C. cannabis sales which for years was added onto the federal budget by Rep. Andy Harris (R-MD). 

The prohibition on sales has created an industry of discrete “pop-up” marketplaces, often staged at a private residence or other location revealed only to attendees. Though these underground “dispensaries” are often heavily-guarded, they are also frequent targets of police raids and violent crime, particularly robbery, since perpetrators know vendors are in a legal grey area and unlikely to call the police or report the incident.

Recent movement on D.C. cannabis sales

Early in 2021, the government moved to rectify the situation through local legislation. Two separate bills have been introduced: Mayor Muriel Bowser’s Safe Cannabis Sales Act of 2021, and Councilmember Phil Mendelson’s Comprehensive Cannabis Legalization and Regulation Act of 2021. 

The bills are similar but contain some important differences. Mayor Bowser’s bill sets specific caps on the amount of revenue to be put towards community grants and business startup assistance, while Councilman Mendelson’s bill devotes 50% of cannabis revenue into a Community Reinvestment Fund and 30% into a Social Equity Fund to provide loans and assistance to social equity license applicants. The Mayor’s bill also limits license types to just five kinds, although both bills create microbusiness license categories. Bowser’s bill also has a higher tax rate at 17%, compared to 13% in Mendelson’s proposal.

Comparing bills and predicting the future

Activists seem to have a clear preference for Councilmember Mendelson’s plan.

“The mayor’s bill doesn’t even deserve to be taken seriously,” said Adam Eidinger, founder of advocacy group DC Marijuana Justice and an integral figure in the passing of Initiative 71 in the District. 

Eidinger told Cannabis Business Times and Cannabis Dispensary that Bowser’s bill would effectively end homegrow, an important provision in legalization bills that provides for equitable access to cannabis.

“It has a ten-ounce rule. … You can’t have more than ten ounces of cannabis in your house under her bill,” added Eidinger. “Why is that even in there? It’s in there to enrich the corporate establishment that doesn’t like home cultivation.”

Eidinger argued that any legalization bill should go the opposite direction and raise or remove the current six-plant limit. He stressed that the District would be best served by the creation of a “cottage industry” for cannabis, similar to craft beer or produce.

“We’re going to the councilmembers systematically and we’re asking them, ‘Have you considered casual sales first? Have you considered farmers’ markets and giving home growers a lawful way to sell their cannabis?’” said Eidinger. 

“What we’re not fighting for is a closed, high-barrier to entry [industry with] limited numbers of licenses for cultivators and sellers. We would rather see the free market roll. … Let the chips fall where they may and the best companies rise to the top. … I think we can get a cottage industry here—we are really suited for it.”

In March, the Drug Policy Alliance also released a statement expressing preference for Councilman Mendelson’s bill.

Morgan Fox, media relations director for the National Cannabis Industry Association, which has offices in the District, agreed that cannabis sales will likely be allowed in D.C. sooner rather than late—possibly even before federal movement on cannabis.

“I think that the chances of Congress passing an appropriations bill that omits the Harris rider are much greater this year than the chances of Congress descheduling cannabis,” said Fox via email. “Given that Mayor Bowser has publicly stated that DC regulators are already preparing for the passage of either regulatory bill before the Council, I’d say the probability of DC regulating cannabis before the federal government starts that process is fairly high.”

What about statehood?

Some believe that D.C. might need to first achieve statehood to shirk the restrictions imposed by Congress. H.R. 51, a resolution to turn the residential and commercial parts of the District into the country’s 51st state, passed in the House last month.

But with a razor-thin Democratic margin in the Senate and moderate Sen. Joe Manchin (D-WV) publicly announcing his opposition to the proposal, D.C. doesn’t currently have a realistic path to statehood.

“I’m pretty pessimistic about statehood at this point,” said Eidinger. “The real assessment of it is that people like Joe Manchin are standing in the way of it.” Fox also agreed that D.C. was likely to pass a bill regulating cannabis sales before the government granting statehood to the District.

That means it’s likely to come down to legislators, activists and constituents in D.C. to create the kind of equitable cannabis industry that the District of Columbia—with its rich history of Black and brown prosperity—deserves.

The average dispensary in Las Vegas pulls in about $2 million in revenue per month, while larger stores have reported up to $10 million in single-month sales. Even in 2020, amidst the COVID-19 pandemic, legal cannabis statewide in Nevada clocked $789 million in sales. And prospective business owners want in: State-issued licenses have traded hands for as much as $20 million each.

Owning a cannabis company in the Silver State can be an incredibly lucrative endeavor. But for all of the Green Rush’s successes—80 operating dispensaries, 158 grow houses and 110 production facilities—still only one company has a Black woman running the show from the top.

On the remote east side of Sin City, just before houses and roads give way to miles of desert sand, a mom-and-pop-style cannabis store serves thousands of mostly local residents. Top Notch The Health Center, styled as Top Notch THC next to a bright green medical cross on its cream-colored building, welcomes a broad customer base.

Kema Ogden is one of three Top Notch owners and still the only Black woman able to make such a claim in Nevada. Unlike most of her counterparts in the industry, who have sold off their marijuana empires for up to $300 million, Ogden has held onto her dispensary. She’s also still regularly involved in the day-to-day operations.

“We’ve always been focused on being a grassroots company and being a part of the local community,” she said. “The community supports us back, and those relationships that we’ve built over the years really help keep us grounded.”

A former fitness trainer and philanthropist, Ogden would have called you crazy a decade ago if you told her that part of her future would be dealing legal weed. The wife of NFL Hall-of-Famer Jonathan Ogden and mother of two has always had a heart for wellness and helping others. But her humanitarian endeavors had always taken more traditional structures, like a family foundation that runs sports and fitness programs as well as a nonprofit hospital that serves uninsured and low-income families.

With marijuana, she gets the best of both worlds: promoting wellness and making a pretty penny doing it.

“Of course, this is a business for us and we’re always considering opportunities to expand and reach more people,” she said. “But cannabis has become a healthy part of a holistic wellness approach for a lot of our customers.”

Small and Friendly, but Not a Boutique

Top Notch is easily one of the state’s smallest dispensaries, with only 1,500 square feet of retail space. Yet the store is anything but a boutique. It carries over 1,600 cannabis products, including hard-to-find medical specialties like Rick Simpson Oil and patient-grade edibles featuring up to eight times more THC than the state’s limit for recreational products.

Its massive selection ranks Top Notch near the top of all dispensaries in the sheer number of items consumers can choose from. Ogden attributed her store’s large supply to remembering why she and partners got into the business in the first place.

“We try to stay patient-orientated because that’s ultimately why we’re here,” she said. “There’s enough money to be made on retail customers where you can still serve the people out there that really need cannabis to make their lives better.”

Unlike just about every other cannabis store in town, Ogden makes her budtenders available for one-on-one consultations from the time a customer steps into the waiting area to when they walk out the exit. Picture a doctor’s office: the nurse opens the door to the waiting room and calls your name, then walks alongside you before sitting down to discuss your needs. Top Notch doesn’t have licensed medical professionals, but the patient process is otherwise identical.

A Family Atmosphere

For many of the 65 employees at Top Notch, working at the dispensary has been a calling fulfilled. Interviewed employees said their jobs are altruistic in the sense that they can advise shoppers seeking physical and mental support on the plant’s benefits for their ailments.

While most cannabis stores across the Vegas Valley have seen their fair share of turnover and turmoil amidst lucrative ownership changes and restructuring, five of Top Notch’s original six employees continue to work at the dispensary to this day.

Lashawn Griego moved down to Vegas from Denver when the store first opened in late 2015. A former kindergarten teacher and occupational health professional, Griego credits Ogden for creating a family-like atmosphere for employees to thrive.

Griego, who like Ogden is a Black woman, started as a greeter at Top Notch’s front door. In six years, she’s worked her way up to being the store’s general manager and now oversees all of the store’s other employees.

Courtesy of Top Notch THC

“I’ve never really stopped to think about my own accomplishments because this is a company I worked hard to grow in,” Griego said. “We’re all laid back and I don’t look at myself as being a caliber above anyone else here. If we’re slammed, I’ll jump in as a budtender. I’ll get behind the desk and I’ll answer the phones. I’ll be security if they need me to.”

Griego, 49, credits Ogden for helping her ascend to a career she otherwise wouldn’t have realized.

“She just encourages and motivates you and gets you to where you want to be,” Griego said. “She saw value in me before I saw it in myself.”

Blazing a Trail for Others

A January 2021 report from the state’s Cannabis Compliance Board showed Nevada’s marijuana industry is pretty diverse as a whole. Over 38% of people involved in the industry are women, a quarter are Hispanic and nearly 11 percent are Black or African American. The percentage breakdowns for race are relatively consistent with the state’s population of 3.2 million people.

A closer look at the report, though, shows most of the women and minority stakeholders skew toward the bottom levels of the totem pole—think receptionists, budtenders and security. At the top, white men account for nearly three-quarters of company owners.

Previous state initiatives designed to level the ownership playing field have essentially been nothing more than lip service from politicians to underrepresented groups, Ogden said. 2017 regulations incentivizing companies to add women and minorities as owners, executives or board members gave way to a host of new “sham boards” in which minorities received new fancy-sounding titles but had no real impact on the companies they worked for.

Still, Ogden insists there’s hope for the future. Recently appointed by Nevada’s governor to a 12-member Cannabis Advisory Commission, she pointed to a bill at this year’s state legislature that would let cannabis lounges open. The bill would also allow for entertainment operators to apply for permits so patrons could smoke at festivals and music concerts.

The new permits won’t be capped by the state. And less barriers to entry means more minority owners will have a shot at owning a cannabis business.

“Equality is something I’m very passionate about, and the ideas we have out there now are steps in the right direction,” Ogden said. “When we start getting more diversity at the ownership table, I think this industry will flourish in ways we’ve never seen before.”

Environmentally conscious manufacturing has never been more important; for the survival of both the planet and your business. The internet makes CBD product comparisons quick and efficient, so consumers can interrogate every aspect of your product and processes before deciding to make a purchase. Sustainability credentials are now a primary decision making factor for your customers.

For business of all sizes, improving resource use and efficiency is a great place to start. This will reduce waste and improve your environmental impact, and has the added benefit of improving your return on investment!

I always recommend investing in stainless steel equipment for manufacturing and distributing CBD oils. Stainless steel is one of the most environmentally efficient raw materials, because of its durability and ability to be recycled. Vessels last an extremely long time, and even once their service life is over, they should never enter the waste stream. Many of our US customers transport their CBD products around the world in stainless steel vessels, which can then either be shipped back for re-use, or re-used at the recipient site.

In terms of finding your ideal equipment supplier, those who have won awards for their environmental initiatives are the cream of the crop; they can be a real asset to your business and will often collaborate on sustainability-themed social content, which is really valuable to get in front of your customers.

Once you’ve investigated the credentials of suitable suppliers, how do you make sure their blending equipment will perfectly meet your needs?

Here are my recommended four points for consideration:

1. 

   Vessel Capacity: Vessel capacity must be considered in two ways; maximum and minimum working capacity. Standard vessels have their capacity listed as ‘brim full’ – suppliers tell you the total overall volume of space in the vessel. However, maximum capacity must allow for 10-20% free space below ‘brim full’, so that if product is being mixed and stirred, there is no overspill. For example; to blend 75L batches of CBD oil, it’s generally recommended to purchase a 100L mixing vessel.

2. Vessel Bottom Shape: Standard vessels have flat bottoms, which makes it difficult to drain them to completely empty. An experienced supplier such as Pharma Hygiene Products has the capability to modify standard vessels, to include a sloped bottom at 3 degrees, which reduces leftover product pooling when draining your oils. Vessels can also be custom-made with a cone or dish shaped bottom, whereby a valve can be positioned in the centre of the base to allow full draining, to reduce waste and increase profitability.
3. Stainless Steel Grade: Stainless steel blending vessels for CBD oils are generally offered in 304 or 316L pharmaceutical-grade material. A simple description of the difference is that 316L grade contains an extra 2% molybdenum, for additional corrosion-resistance. Increased regional and interna­tional legislation concerning CBD products has come hand-in-hand with tighter interrogation of hygiene practices. Contaminant-free materials such as stainless steel are ideal to ensure international pharma-quality compliance for your business’ blending processes. Critically, at Pharma Hygiene Products a comprehensive range of compliance certification is available to confirm the grade of material, to prove surface smoothness, and to guarantee that no cross-contamination from BSE or CJD diseases occurs.

   

4. Lastly, don’t forget to let your supplier know in advance if you have any special requirements for your product or vessel. Some common examples include:

• Flammable product components – Requiring ATEX certified blending equipment.
• Temperature control – Adding a water jacket to your vessel is a simple solution for heating, cooling or maintaining the temperature of your product as it blends.
• Toggles and seals – For airtight, contaminant-free transportation.
• Viewing holes – For easy visual inspection whilst blending.

Your equipment supplier can be a real financial and reputational asset, so be sure to do your homework before making an investment!